NCM
IMUX icon

Nantahala Capital Management’s Immunic IMUX Stock Holding History

Nantahala Capital Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.85M Sell
250,646
-3
-0% -$37 0.13% 115
2026
Q1 		$2.78M Sell
250,649
-187,192
-43% -$1.68M 0.1% 123
2025
Q4 		$2.34M Buy
+437,841
New +$3.21M 0.08% 129

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Nantahala Capital Management's IMUX Position: Q2 2026 in Review

Nantahala Capital Management reduced its Immunic (IMUX) stake by 0% in Q2 2026, selling an estimated $37 and leaving 250,646 shares worth $3.85M. The position accounts for 0.13% of the portfolio, ranked #115.

Nantahala Capital Management first reported a position in IMUX in Q4 2025 and has held it in 3 quarters since. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Nantahala Capital Management held 250,646 shares of Immunic worth $3.85M as of Q2 2026.
  • Nantahala Capital Management sold 3 Immunic shares in Q2 2026, an estimated $37.
  • Immunic made up 0.13% of Nantahala Capital Management's portfolio in Q2 2026, its #115 holding.
  • Nantahala Capital Management first reported a position in Immunic in Q4 2025 and has held it in 3 quarters since.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Nantahala Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.